ReP USP - Resultado da busca

Artigo de periodico
Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response (2013)
Rodrigues, Alice Cristina; Sobrino, B; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Bertolami, Marcelo; Faludi, André Arpad; Brion, M. J; Carracedo, Angel; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Clinica Chimica Acta. Unidades: ICB, HU, FCF
Subjects: DISLIPIDEMIAS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina; SOBRINO, B; GENVIGIR, Fabiana Dalla Vecchia; et al. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response. Clinica Chimica Acta, Amsterdam, v. 417, n. 1, p. 8-11, 2013. Disponível em: < http://dx.doi.org/10.1016/j.cca.2012.11.028 > DOI: 10.1016/j.cca.2012.11.028.
APA
Rodrigues, A. C., Sobrino, B., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., Dórea, E. L., et al. (2013). Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response. Clinica Chimica Acta, 417( 1), 8-11. doi:10.1016/j.cca.2012.11.028
NLM
Rodrigues AC, Sobrino B, Genvigir FDV, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Bertolami M, Faludi AA, Brion MJ, Carracedo A, Hirata MH, Hirata RDC. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response [Internet]. Clinica Chimica Acta. 2013 ; 417( 1): 8-11.Available from: http://dx.doi.org/10.1016/j.cca.2012.11.028
Vancouver
Rodrigues AC, Sobrino B, Genvigir FDV, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Bertolami M, Faludi AA, Brion MJ, Carracedo A, Hirata MH, Hirata RDC. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response [Internet]. Clinica Chimica Acta. 2013 ; 417( 1): 8-11.Available from: http://dx.doi.org/10.1016/j.cca.2012.11.028
Artigo de periodico
Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients (2013)
Willrich, Maria Alice Vieira; Rodrigues, Alice Cristina; Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Arazi, Simone Sorkin; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Bertolami, Marcelo Chiara; Faludi, André Arpad; Largura, Alvaro; Baudhuin, Linnea M; Bryant, Sandra C; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Clinica Chimica Acta. Unidades: HU, FCF
Subjects: EXPRESSÃO GÊNICA, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLRICH, Maria Alice Vieira; RODRIGUES, Alice Cristina; CERDA, Alvaro; et al. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients. Clinica Chimica Acta, Amsterdam, v. 421, p. 157-163, 2013. Disponível em: < http://dx.doi.org/10.1016/j.cca.2013.03.007 > DOI: 10.1016/j.cca.2013.03.007.
APA
Willrich, M. A. V., Rodrigues, A. C., Cerda, A., Genvigir, F. D. V., Arazi, S. S., Dórea, E. L., et al. (2013). Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients. Clinica Chimica Acta, 421, 157-163. doi:10.1016/j.cca.2013.03.007
NLM
Willrich MAV, Rodrigues AC, Cerda A, Genvigir FDV, Arazi SS, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Largura A, Baudhuin LM, Bryant SC, Hirata MH, Hirata RDC. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients [Internet]. Clinica Chimica Acta. 2013 ; 421 157-163.Available from: http://dx.doi.org/10.1016/j.cca.2013.03.007
Vancouver
Willrich MAV, Rodrigues AC, Cerda A, Genvigir FDV, Arazi SS, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Largura A, Baudhuin LM, Bryant SC, Hirata MH, Hirata RDC. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients [Internet]. Clinica Chimica Acta. 2013 ; 421 157-163.Available from: http://dx.doi.org/10.1016/j.cca.2013.03.007
Artigo de periodico
Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population (2012)
Silbiger, Vivian Nogueira; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Genvigir, Fabiana Dalla Vecchia; Cerda, Alvaro; Rodrigues, Alice Cristina; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Faludi, André Arpad; Bertolami, Marcelo Chiara; Santos, Carla; Carracedo, Ángel; Salas, Antonio; Freire, Ana; Lareu, Maria Victoria; Phillips, Christopher; Porras-Hurtado, Liliana; Fondevilla, Manuel; Hirata, Rosario Dominguez Crespo
Source: Genetic Testing and Molecular Biomarkers. Unidades: FCF, HU
Subjects: POLIMORFISMO, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILBIGER, Vivian Nogueira; HIRATA, Mario Hiroyuki; LUCHESSI, André Ducati; et al. Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population. Genetic Testing and Molecular Biomarkers, New Rochelle, v. 16, n. 6, p. 524-530, 2012. Disponível em: < http://dx.doi.org/10.1089/gtmb.2011.0267 > DOI: 10.1089/gtmb.2011.0267.
APA
Silbiger, V. N., Hirata, M. H., Luchessi, A. D., Genvigir, F. D. V., Cerda, A., Rodrigues, A. C., et al. (2012). Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population. Genetic Testing and Molecular Biomarkers, 16( 6), 524-530. doi:10.1089/gtmb.2011.0267
NLM
Silbiger VN, Hirata MH, Luchessi AD, Genvigir FDV, Cerda A, Rodrigues AC, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Faludi AA, Bertolami MC, Santos C, Carracedo Á, Salas A, Freire A, Lareu MV, Phillips C, Porras-Hurtado L, Fondevilla M, Hirata RDC. Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population [Internet]. Genetic Testing and Molecular Biomarkers. 2012 ; 16( 6): 524-530.Available from: http://dx.doi.org/10.1089/gtmb.2011.0267
Vancouver
Silbiger VN, Hirata MH, Luchessi AD, Genvigir FDV, Cerda A, Rodrigues AC, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Faludi AA, Bertolami MC, Santos C, Carracedo Á, Salas A, Freire A, Lareu MV, Phillips C, Porras-Hurtado L, Fondevilla M, Hirata RDC. Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population [Internet]. Genetic Testing and Molecular Biomarkers. 2012 ; 16( 6): 524-530.Available from: http://dx.doi.org/10.1089/gtmb.2011.0267
Artigo de periodico
Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response (2011)
Rodrigues, Alice Cristina; Perin, Paula Monteiro dos Santos; Purim, Sheila Gregório; Silbiger, Vivian Nogueira; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Luchessi, André Ducati; Hirata, Mario Hiroyuki ; Bernik, Marcia Martins Silveira; Dórea, Egidio Lima; Santos, Carla; Faludi, André A; Bertolami, Marcelo C; Salas, Antonio; Freire, Ana; Lareu, Maria V; Phillips, Christopher; Porras-Hurtado, Liliana; Fondevila, Manuel; Carracedo, Angel; Hirata, Rosario Dominguez Crespo
Source: International Journal of Molecular Sciences. Unidades: FCF, HU
Subjects: FARMACOTÉCNICA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina; PERIN, Paula Monteiro dos Santos; PURIM, Sheila Gregório; et al. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response. International Journal of Molecular Sciences, Basel, v. 12, p. 5815-5827, 2011. Disponível em: < http://dx.doi.org/10.3390/ijms12095815 > DOI: 10.3390/ijms12095815.
APA
Rodrigues, A. C., Perin, P. M. dos S., Purim, S. G., Silbiger, V. N., Genvigir, F. D. V., Willrich, M. A. V., et al. (2011). Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response. International Journal of Molecular Sciences, 12, 5815-5827. doi:10.3390/ijms12095815
NLM
Rodrigues AC, Perin PM dos S, Purim SG, Silbiger VN, Genvigir FDV, Willrich MAV, Arazi SS, Luchessi AD, Hirata MH, Bernik MMS, Dórea EL, Santos C, Faludi AA, Bertolami MC, Salas A, Freire A, Lareu MV, Phillips C, Porras-Hurtado L, Fondevila M, Carracedo A, Hirata RDC. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response [Internet]. International Journal of Molecular Sciences. 2011 ; 12 5815-5827.Available from: http://dx.doi.org/10.3390/ijms12095815
Vancouver
Rodrigues AC, Perin PM dos S, Purim SG, Silbiger VN, Genvigir FDV, Willrich MAV, Arazi SS, Luchessi AD, Hirata MH, Bernik MMS, Dórea EL, Santos C, Faludi AA, Bertolami MC, Salas A, Freire A, Lareu MV, Phillips C, Porras-Hurtado L, Fondevila M, Carracedo A, Hirata RDC. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response [Internet]. International Journal of Molecular Sciences. 2011 ; 12 5815-5827.Available from: http://dx.doi.org/10.3390/ijms12095815
Artigo de periodico
Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression (2011)
Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina; Willrich, Maria Alice Vieira; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Arazi, Simone Sorkin; Oliveira, Raquel de; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Journal of Atherosclerosis and Thrombosis. Unidades: HU, FCF
Subjects: EXPRESSÃO GÊNICA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro; GENVIGIR, Fabiana Dalla Vecchia; RODRIGUES, Alice Cristina; et al. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Journal of Atherosclerosis and Thrombosis, Tokyo, v. 18, n. 8, p. 640-651, 2011.
APA
Cerda, A., Genvigir, F. D. V., Rodrigues, A. C., Willrich, M. A. V., Dórea, E. L., Bernik, M. M. S., et al. (2011). Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Journal of Atherosclerosis and Thrombosis, 18( 8), 640-651.
NLM
Cerda A, Genvigir FDV, Rodrigues AC, Willrich MAV, Dórea EL, Bernik MMS, Arazi SS, Oliveira R de, Hirata MH, Hirata RDC. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Journal of Atherosclerosis and Thrombosis. 2011 ; 18( 8): 640-651.
Vancouver
Cerda A, Genvigir FDV, Rodrigues AC, Willrich MAV, Dórea EL, Bernik MMS, Arazi SS, Oliveira R de, Hirata MH, Hirata RDC. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Journal of Atherosclerosis and Thrombosis. 2011 ; 18( 8): 640-651.
Trabalho de evento-resumo
Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia (2011)
Rodrigues, A. C; Sobrino, B; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Brion, M. J; Carracedo, A; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Resumos. Conference titles: Congresso Brasileiro de Genética. Unidades: HU, FCF
Subjects: DISLIPIDEMIAS, HIPERCOLESTEROLEMIA, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, A. C; SOBRINO, B; GENVIGIR, Fabiana Dalla Vecchia; et al. Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia. Anais.. Ribeirão Preto: Sociedade Brasileira de Genética (SBG), 2011.
APA
Rodrigues, A. C., Sobrino, B., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., Dórea, E. L., et al. (2011). Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia. In Resumos. Ribeirão Preto: Sociedade Brasileira de Genética (SBG).
NLM
Rodrigues AC, Sobrino B, Genvigir FDV, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Brion MJ, Carracedo A, Hirata MH, Hirata RDC. Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia. Resumos. 2011 ;
Vancouver
Rodrigues AC, Sobrino B, Genvigir FDV, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Brion MJ, Carracedo A, Hirata MH, Hirata RDC. Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia. Resumos. 2011 ;
Artigo de periodico
Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin (2011)
Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Bernik, Marcia Martins Silveira; Dórea, Egidio Lima; Bertolami, Marcelo Chiara; Faludi, André Arpad; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Lipids in Health and Disease. Unidades: FCF, HU
Subjects: APOLIPOPROTEÍNAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro; GENVIGIR, Fabiana Dalla Vecchia; WILLRICH, Maria Alice Vieira; et al. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin. Lipids in Health and Disease, London, v. 10, p. 1-11, 2011. Disponível em: < http://dx.doi.org/10.1186/1476-511X-10-206 > DOI: 10.1186/1476-511X-10-206.
APA
Cerda, A., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., Bernik, M. M. S., Dórea, E. L., et al. (2011). Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin. Lipids in Health and Disease, 10, 1-11. doi:10.1186/1476-511X-10-206
NLM
Cerda A, Genvigir FDV, Willrich MAV, Arazi SS, Bernik MMS, Dórea EL, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin [Internet]. Lipids in Health and Disease. 2011 ; 10 1-11.Available from: http://dx.doi.org/10.1186/1476-511X-10-206
Vancouver
Cerda A, Genvigir FDV, Willrich MAV, Arazi SS, Bernik MMS, Dórea EL, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin [Internet]. Lipids in Health and Disease. 2011 ; 10 1-11.Available from: http://dx.doi.org/10.1186/1476-511X-10-206
Tese
Efeitos de hipolipemiantes sobre a expressão de CYP3A4 e CYP3A5 in vitro e in vivo (2011)
Willrich, Maria Alice Vieira; Hirata, Rosario Dominguez Crespo (Orientador)
Unidade: FCF
Subjects: TÉCNICAS E PROCEDIMENTOS DE LABORATÓRIO, EXPRESSÃO GÊNICA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLRICH, Maria Alice Vieira; HIRATA, Rosario Dominguez Crespo. Efeitos de hipolipemiantes sobre a expressão de CYP3A4 e CYP3A5 in vitro e in vivo. 2011.Universidade de São Paulo, São Paulo, 2011. Disponível em: < http://www.teses.usp.br/teses/disponiveis/9/9136/tde-12092012-150610/ >.
APA
Willrich, M. A. V., & Hirata, R. D. C. (2011). Efeitos de hipolipemiantes sobre a expressão de CYP3A4 e CYP3A5 in vitro e in vivo. Universidade de São Paulo, São Paulo. Recuperado de http://www.teses.usp.br/teses/disponiveis/9/9136/tde-12092012-150610/
NLM
Willrich MAV, Hirata RDC. Efeitos de hipolipemiantes sobre a expressão de CYP3A4 e CYP3A5 in vitro e in vivo [Internet]. 2011 ;Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-12092012-150610/
Vancouver
Willrich MAV, Hirata RDC. Efeitos de hipolipemiantes sobre a expressão de CYP3A4 e CYP3A5 in vitro e in vivo [Internet]. 2011 ;Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-12092012-150610/
Trabalho de evento-resumo periodico
Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals (2010)
Willrich, Maria Alice Vieira; Genvigir, Fabiana Dalla Vecchia; Rodrigues, A. C; Arazi, Simone Sorkin; Oliveira, R; Hirata, Mario Hiroyuki ; Dórea, Egidio Lima; Hirata, Rosario Dominguez Crespo
Source: Clinical Chemistry. Conference titles: American Association for Clinical Chemistry Annual Meeting/AACC. Unidades: FCF, HU
Subjects: HIPERCOLESTEROLEMIA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLRICH, Maria Alice Vieira; GENVIGIR, Fabiana Dalla Vecchia; RODRIGUES, A. C; et al. Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry[S.l: s.n.], 2010.
APA
Willrich, M. A. V., Genvigir, F. D. V., Rodrigues, A. C., Arazi, S. S., Oliveira, R., Hirata, M. H., et al. (2010). Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. Washington.
NLM
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Hirata MH, Dórea EL, Hirata RDC. Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. 2010 ; 56( 6 suppl.): A89-A90 res. B-117.
Vancouver
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Hirata MH, Dórea EL, Hirata RDC. Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. 2010 ; 56( 6 suppl.): A89-A90 res. B-117.
Trabalho de evento-resumo periodico
CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy (2010)
Willrich, Maria Alice Vieira; Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina; Arazi, Simone Sorkin; Oliveira, Raquel de; Maureira, Alvaro Danilo Cerda; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidades: HU, FCF
Subjects: HIPERCOLESTEROLEMIA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLRICH, Maria Alice Vieira; GENVIGIR, Fabiana Dalla Vecchia; RODRIGUES, Alice Cristina; et al. CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy. Brazilian Journal of Pharmaceutical Sciences[S.l: s.n.], 2010.
APA
Willrich, M. A. V., Genvigir, F. D. V., Rodrigues, A. C., Arazi, S. S., Oliveira, R. de, Maureira, A. D. C., et al. (2010). CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo.
NLM
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R de, Maureira ADC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 44 res. FCF084.
Vancouver
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R de, Maureira ADC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 44 res. FCF084.
Trabalho de evento-resumo
Associação de polimorfismos dos genes LEP, LEPR e ADIPOQ com aumento da resistencia à insulina em indivíduos obesos (2010)
Oliveira, Raquel; Genvigir, Fabiana Dalla Vecchia; Cerda, Alvaro; Willrich, Maria Alice Vieira; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Jorge, Mie; Fajardo, Cristina Moreno; Martinez, Marina Baquerizo; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Resumos. Conference titles: Endocrino. Unidades: FCF, HU
Subjects: INSULINA (RESISTÊNCIA), POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Raquel; GENVIGIR, Fabiana Dalla Vecchia; CERDA, Alvaro; et al. Associação de polimorfismos dos genes LEP, LEPR e ADIPOQ com aumento da resistencia à insulina em indivíduos obesos. Anais.. Porto Alegre: Sociedade Brasileira de Endocrinologia e Metabologia, 2010.
APA
Oliveira, R., Genvigir, F. D. V., Cerda, A., Willrich, M. A. V., Dórea, E. L., Bernik, M. M. S., et al. (2010). Associação de polimorfismos dos genes LEP, LEPR e ADIPOQ com aumento da resistencia à insulina em indivíduos obesos. In Resumos. Porto Alegre: Sociedade Brasileira de Endocrinologia e Metabologia.
NLM
Oliveira R, Genvigir FDV, Cerda A, Willrich MAV, Dórea EL, Bernik MMS, Jorge M, Fajardo CM, Martinez MB, Hirata MH, Hirata RDC. Associação de polimorfismos dos genes LEP, LEPR e ADIPOQ com aumento da resistencia à insulina em indivíduos obesos. Resumos. 2010 ;
Vancouver
Oliveira R, Genvigir FDV, Cerda A, Willrich MAV, Dórea EL, Bernik MMS, Jorge M, Fajardo CM, Martinez MB, Hirata MH, Hirata RDC. Associação de polimorfismos dos genes LEP, LEPR e ADIPOQ com aumento da resistencia à insulina em indivíduos obesos. Resumos. 2010 ;
Trabalho de evento-resumo periodico
The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response (2010)
Rodrigues, Alice Cristina; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Hirata, Mario Hiroyuki ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidades: FCF, HU
Subjects: POLIMORFISMO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina; GENVIGIR, Fabiana Dalla Vecchia; WILLRICH, Maria Alice Vieira; et al. The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response. Brazilian Journal of Pharmaceutical Sciences[S.l: s.n.], 2010.
APA
Rodrigues, A. C., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., Hirata, M. H., Dórea, E. L., et al. (2010). The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response. Brazilian Journal of Pharmaceutical Sciences. São Paulo.
NLM
Rodrigues AC, Genvigir FDV, Willrich MAV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 77 res. FCF149.
Vancouver
Rodrigues AC, Genvigir FDV, Willrich MAV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 77 res. FCF149.
Artigo de periodico
Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells (2010)
Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina; Cerda, Alvaro; Arazi, Simone Sorkin; Willrich, Maria Alice Vieira; Oliveira, Raquel; Hirata, Mario Hiroyuki ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Curi, Rui; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidades: FCF, HU, ICB
Subjects: EXPRESSÃO GÊNICA, COLESTEROL, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia; RODRIGUES, Alice Cristina; CERDA, Alvaro; et al. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells. Pharmacogenomics, London, v. 11, n. 9, p. 1235-1246, 2010. Disponível em: < http://dx.doi.org/10.2217/pgs.10.93 > DOI: 10.2217/pgs.10.93.
APA
Genvigir, F. D. V., Rodrigues, A. C., Cerda, A., Arazi, S. S., Willrich, M. A. V., Oliveira, R., et al. (2010). Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells. Pharmacogenomics, 11( 9), 1235-1246. doi:10.2217/pgs.10.93
NLM
Genvigir FDV, Rodrigues AC, Cerda A, Arazi SS, Willrich MAV, Oliveira R, Hirata MH, Dórea EL, Bernik MMS, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells [Internet]. Pharmacogenomics. 2010 ; 11( 9): 1235-1246.Available from: http://dx.doi.org/10.2217/pgs.10.93
Vancouver
Genvigir FDV, Rodrigues AC, Cerda A, Arazi SS, Willrich MAV, Oliveira R, Hirata MH, Dórea EL, Bernik MMS, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells [Internet]. Pharmacogenomics. 2010 ; 11( 9): 1235-1246.Available from: http://dx.doi.org/10.2217/pgs.10.93
Trabalho de evento-resumo periodico
Effects of statins on expression of genes involved in reverse cholesterol transport in hepg2 cells (2009)
Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina; Hirata, Mario Hiroyuki ; Willrich, Maria Alice Vieira; Curi, Rui; Hirata, Rosario Dominguez Crespo
Source: Atherosclerosis Supplements. Conference titles: Brazilian Congress of Atherosclerosis. Unidades: FCF, ICB
Subjects: EXPRESSÃO GÊNICA, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia; RODRIGUES, Alice Cristina; HIRATA, Mario Hiroyuki; et al. Effects of statins on expression of genes involved in reverse cholesterol transport in hepg2 cells. Atherosclerosis Supplements[S.l: s.n.], 2009.
APA
Genvigir, F. D. V., Rodrigues, A. C., Hirata, M. H., Willrich, M. A. V., Curi, R., & Hirata, R. D. C. (2009). Effects of statins on expression of genes involved in reverse cholesterol transport in hepg2 cells. Atherosclerosis Supplements. Amsterdam.
NLM
Genvigir FDV, Rodrigues AC, Hirata MH, Willrich MAV, Curi R, Hirata RDC. Effects of statins on expression of genes involved in reverse cholesterol transport in hepg2 cells. Atherosclerosis Supplements. 2009 ; 10( 3): 13 res. D004.
Vancouver
Genvigir FDV, Rodrigues AC, Hirata MH, Willrich MAV, Curi R, Hirata RDC. Effects of statins on expression of genes involved in reverse cholesterol transport in hepg2 cells. Atherosclerosis Supplements. 2009 ; 10( 3): 13 res. D004.
Artigo de periodico
Statin regulation of CYP3A4 and CYP3A5 expression (2009)
Willrich, Maria Alice Vieira; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidade: FCF
Subjects: FARMACOGENÉTICA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLRICH, Maria Alice Vieira; HIRATA, Mario Hiroyuki; HIRATA, Rosario Dominguez Crespo. Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics, London, v. 10, n. 6, p. 1017-1024, 2009. DOI: 10.2217/pgs.09.42.
APA
Willrich, M. A. V., Hirata, M. H., & Hirata, R. D. C. (2009). Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics, 10( 6), 1017-1024. doi:10.2217/pgs.09.42
NLM
Willrich MAV, Hirata MH, Hirata RDC. Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics. 2009 ; 10( 6): 1017-1024.
Vancouver
Willrich MAV, Hirata MH, Hirata RDC. Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics. 2009 ; 10( 6): 1017-1024.
Trabalho de evento-resumo periodico
Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response (2009)
Rodrigues, Alice Cristina; Perin, P. M.; Purim, S.; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Hirata, Mario Hiroyuki ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Rosario Dominguez Crespo
Source: Clinical Chemistry. Conference titles: Annual Meeting of the American Association for Clinical Chemistry. Unidades: FCF, HU
Assunto: LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina; PERIN, P. M.; PURIM, S.; et al. Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response. Clinical Chemistry[S.l: s.n.], 2009.
APA
Rodrigues, A. C., Perin, P. M., Purim, S., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., et al. (2009). Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response. Clinical Chemistry. Washington: American Association for Clinical Chemistry.
NLM
Rodrigues AC, Perin PM, Purim S, Genvigir FDV, Willrich MAV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response. Clinical Chemistry. 2009 ; 55( 6 suppl.): A87 res. B-120.
Vancouver
Rodrigues AC, Perin PM, Purim S, Genvigir FDV, Willrich MAV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response. Clinical Chemistry. 2009 ; 55( 6 suppl.): A87 res. B-120.
Trabalho de evento-resumo periodico
mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy (2008)
Arazi, Simone Sorkin; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Hirata, Mario Hiroyuki ; Oliveira, R.; Dorea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Rosario Dominguez Crespo
Source: Clinical Chemistry. Conference titles: AACC Annual Meeting. Unidades: FCF, HU
Subjects: EXPRESSÃO GÊNICA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAZI, Simone Sorkin; GENVIGIR, Fabiana Dalla Vecchia; WILLRICH, Maria Alice Vieira; et al. mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy. Clinical Chemistry[S.l: s.n.], 2008.
APA
Arazi, S. S., Genvigir, F. D. V., Willrich, M. A. V., Hirata, M. H., Oliveira, R., Dorea, E. L., et al. (2008). mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy. Clinical Chemistry. Washington.
NLM
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Oliveira R, Dorea EL, Bernik MMS, Hirata RDC. mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy. Clinical Chemistry. 2008 ;54( 6): A150 res.D-21.
Vancouver
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Oliveira R, Dorea EL, Bernik MMS, Hirata RDC. mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy. Clinical Chemistry. 2008 ;54( 6): A150 res.D-21.
Trabalho de evento-resumo
Alteração da expressão dos transportadores do tipo ABC e SLC no estado hiperlipidêmico e após tratamento com atorvastatina (2008)
Rodrigues, Alice Cristina; Genvigir, Fabiana Dalla Vecchia; Arazi, Simone Sorkin; Willrich, Maria Alice Vieira; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Programa & Resumos. Conference titles: São Paulo Research Conferences Medicina Molecular e Farmacogenética. Unidade: FCF
Subjects: HIPERLIPIDEMIA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina; GENVIGIR, Fabiana Dalla Vecchia; ARAZI, Simone Sorkin; et al. Alteração da expressão dos transportadores do tipo ABC e SLC no estado hiperlipidêmico e após tratamento com atorvastatina. Anais.. São Paulo: Pró-Reitoria de Pesquisa, 2008.
APA
Rodrigues, A. C., Genvigir, F. D. V., Arazi, S. S., Willrich, M. A. V., Dórea, E. L., Bernik, M. M. S., et al. (2008). Alteração da expressão dos transportadores do tipo ABC e SLC no estado hiperlipidêmico e após tratamento com atorvastatina. In Programa & Resumos. São Paulo: Pró-Reitoria de Pesquisa.
NLM
Rodrigues AC, Genvigir FDV, Arazi SS, Willrich MAV, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. Alteração da expressão dos transportadores do tipo ABC e SLC no estado hiperlipidêmico e após tratamento com atorvastatina. Programa & Resumos. 2008 ;
Vancouver
Rodrigues AC, Genvigir FDV, Arazi SS, Willrich MAV, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. Alteração da expressão dos transportadores do tipo ABC e SLC no estado hiperlipidêmico e após tratamento com atorvastatina. Programa & Resumos. 2008 ;
Artigo de periodico
Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response (2008)
Arazi, Simone Sorkin; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Hirata, Mario Hiroyuki ; Dorea, Egidio Lima; Bernik, Márcia Martins Silveira; Hirata, Rosario Dominguez Crespo
Source: Clinica Chimica Acta. Unidades: FCF, HU
Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAZI, Simone Sorkin; GENVIGIR, Fabiana Dalla Vecchia; WILLRICH, Maria Alice Vieira; et al. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response. Clinica Chimica Acta, Amsterdam, v. 393, n. 2, p. 119-124, 2008. Disponível em: < http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T57-4S7JG15-1-9&_cdi=4995&_user=5674931&_orig=browse&_coverDate=07%2F17%2F2008&_sk=996069997&view=c&wchp=dGLbVzb-zSkzS&md5=c7c4517dc3a73541c26a91e0e6aedede&ie=/sdarticle.p > DOI: 10.1016/j.cca.2008.03.031.
APA
Arazi, S. S., Genvigir, F. D. V., Willrich, M. A. V., Hirata, M. H., Dorea, E. L., Bernik, M. M. S., & Hirata, R. D. C. (2008). Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response. Clinica Chimica Acta, 393( 2), 119-124. doi:10.1016/j.cca.2008.03.031
NLM
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response [Internet]. Clinica Chimica Acta. 2008 ; 393( 2): 119-124.Available from: http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T57-4S7JG15-1-9&_cdi=4995&_user=5674931&_orig=browse&_coverDate=07%2F17%2F2008&_sk=996069997&view=c&wchp=dGLbVzb-zSkzS&md5=c7c4517dc3a73541c26a91e0e6aedede&ie=/sdarticle.p
Vancouver
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response [Internet]. Clinica Chimica Acta. 2008 ; 393( 2): 119-124.Available from: http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T57-4S7JG15-1-9&_cdi=4995&_user=5674931&_orig=browse&_coverDate=07%2F17%2F2008&_sk=996069997&view=c&wchp=dGLbVzb-zSkzS&md5=c7c4517dc3a73541c26a91e0e6aedede&ie=/sdarticle.p
Trabalho de evento-resumo periodico
mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy (2008)
Arazi, Simone Sorkin; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Hirata, Mario Hiroyuki ; Nakandakare, Edna Regina; Neves, M. S. T.; Hirata, Rosario Dominguez Crespo
Source: Clinical Chemistry and Laboratory Medicine. Conference titles: International Congress of Clinical Chemistry and Laboratory Medicine/IFCC-WorldLab. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAZI, Simone Sorkin; GENVIGIR, Fabiana Dalla Vecchia; WILLRICH, Maria Alice Vieira; et al. mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy. Clinical Chemistry and Laboratory Medicine[S.l: s.n.], 2008.
APA
Arazi, S. S., Genvigir, F. D. V., Willrich, M. A. V., Hirata, M. H., Nakandakare, E. R., Neves, M. S. T., & Hirata, R. D. C. (2008). mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy. Clinical Chemistry and Laboratory Medicine. Berlin.
NLM
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Nakandakare ER, Neves MST, Hirata RDC. mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S570 res. W070.
Vancouver
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Nakandakare ER, Neves MST, Hirata RDC. mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S570 res. W070.

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Non normalized affiliation